Health

ProfoundBio Highlights Broad Antitumor Activity in Preclinical Models and Trial-in-Progress for PRO1184 at AACR 2023 Annual Meeting

WOODINVILLE, Wash. and SUZHOU, China, March 24, 2023 /PRNewswire/ -- ProfoundBio, a clinical stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential, will present two posters from its lead program, PRO1184, a folate receptor alpha (FRα)-...

2023-03-24 20:00 3159

Orion Health strengthens North American operations with new technology and leadership

Amadeus Unified Healthcare Platform set to change healthcare in North America AUCKLAND, New Zealand, March 24, 2023 /PRNewswire/ -- Orion Health, a global leader in population health software, is strengthening its position inNorth America with new technology and the appointment of James Rice as E...

2023-03-24 20:00 1996

Clear Medical Imaging and See-Mode Technologies Announce Partnership via CureLabs Innovation Hub

MELBOURNE, Australia, March 23, 2023 /PRNewswire/ -- Clear Medical Imaging, a leading provider of radiology services and the second largest independent healthcare provider inOntario, announces partnership with See-Mode Technologies to adopt See-Mode, an artificial intelligence (AI) software appli...

2023-03-23 21:00 1877

AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023

NEW YORK, March 23, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platf...

2023-03-23 20:00 2795

111, Inc. Announces Fourth Quarter and Fiscal Year 2022 Financial Results

SHANGHAI, March 23, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the fourth qua...

2023-03-23 14:17 2909

Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma

SUZHOU, China and ROCKVILLE, Md., March 22, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its annual results for the full year 2022. During...

2023-03-23 00:22 2959

Jacobio Pharma Announces 2022 Annual Results

BEIJING, SHANGHAI and BOSTON, March 22, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced its 2022 annual results. R&D investment wasRMB530 million, showing an increase of 26% compared with 2021. The revenue wasRMB95.7 million, which was generated from an out-licensing deal. Jacobio Pharma ...

2023-03-22 22:38 3205

Jolly Good and Harvard University Hospital collaborate on medical VR - Full-scale entry into the U.S. market

~ Dr. Kei Ouchi, Associate Professor of Medicine at Harvard Medical School, appointed as Jolly Good Medical Advisor ~ TOKYO, March 22, 2023 /PRNewswire/ -- (Chuo-ku, Tokyo; President: Kensuke Joji ; hereinafter "Jolly Good"), in collaboration with Brigham and Women's Hospital (Boston, Massachuset...

2023-03-22 21:00 2064

CARsgen Announced 2022 Annual Results and Business Updates

SHANGHAI, March 22, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2022 Annual Results. Business Highlights * Zevor-cel (CT053)...

2023-03-22 20:50 2121

Biosion bispecific antibody therapies to be featured at the American Association for Cancer Research (AACR) annual meeting 2023

NEWARK, Del., March 22, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced the upcoming presentations of non-clinical data from its oncology pipeline, including BSI-507: anti-PD1ⅹanti-PVRIG bispecific antibody and BSI-508: anti-PD1ⅹanti-CD47 bis...

2023-03-22 20:19 1638

WuXi Biologics Reports Remarkable 2022 Annual Results

Revenue Increased by 48.4% Y-o-Y to RMB15,268.7 Million Gross Profit Increased by 39.2% Y-o-Y to RMB6,724.0 Million Adjusted Net Profit Rose by 47.1% to RMB5,053.9 Million Non-COVID Revenue Achieved 63% Y-o-Y Growth, Strong Momentum Continues into 2023 and Beyond "R" in CRDMO Business Model A...

2023-03-22 20:09 3070

Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery

HANGZHOU, China, March 22, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, "the Company"), one of the leading players in the neuro- and peripheral-vascular interventional medical device market inChina , announced its plans to provide free replacement services for produc...

2023-03-22 15:26 1901

Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer

BEIJING, SHANGHAI and BOSTON, March 22, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co., Inc.,Rahway, NJ, USA to evaluate the combination of Jacobio's CD73 monoclonal antibody JAB-BX102 in combination with Merck & Co., Inc., Ra...

2023-03-22 12:36 1963

280Bio Provides Update on the KRAS Inhibitor TEB-17231 at the 2023 AACR Annual Meeting

A broadly acting KRAS Inhibitor, TEB-17231, robustly blocks tumor growth and overcomes KRASG12C inhibitor mediated resistance SHANGHAI, March 21, 2023 /PRNewswire/ -- 280Bio, Inc. a clinical stage biotechnology company, focused on the development of precision oncology medicines, today announced ...

2023-03-21 20:00 1497

Zepp Health Corporation Reports Fourth Quarter and Full Year 2022 Unaudited Financial Results

BEIJING, March 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues ofRMB1.1 billion (US$155.4 million); a GAAP basic and diluted net loss per share of RMB0.31 (US$0.04); and a GAAP basic and diluted net loss per ADS ofRMB1.23 (US$0.18) f...

2023-03-21 19:16 2850

Mindset Health raises US$12m to expand digital hypnotherapy apps & scale distribution

Growth to be supported with new talent attracted to a tech company helping people in need MELBOURNE, Australia, March 21, 2023 /PRNewswire/ -- Mindset Health , the digital hypnotherapy company, today announced it has raisedUS$12 (A$17.8) million in an oversubscrib...

2023-03-21 18:00 1725

So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2022 Financial Results

BEIJING, March 21, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial resu...

2023-03-21 17:00 2135

Kintor Pharma's KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023

SUZHOU, China, March 21, 2023 /PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to21 March 2023 in New Orleans, Louisiana, United States. As one of the largest, most influential and representative of all dermatologic associations, ...

2023-03-21 15:22 1464

Robooter to Showcases Multiple Products at Naidex Under the Theme of "Reboot Your Life"

SHANGHAI, March 20, 2023 /PRNewswire/ -- Robooter will showcase a lineup of products at Naidex 2023, an international healthcare and rehabilitation exhibition held inBirmingham, UK from March 22 to March 23, 2023. Robooter's booth will be located at No. D71, Hall 20 of the International Conventio...

2023-03-21 10:15 1569

WAT Medical Enterprise Initiates Red Cross Charity Campaign Drawing on Part of Revenue from Its New Product

VANCOUVER, BC, March 20, 2023 /PRNewswire/ -- As a proud donor to M.D. Anderson Cancer Center since 2019, WAT Medical Enterprise expands its philanthropic campaign by initiating its Red Cross charity starting in March of 2023. The donationwill be collected from a percentage of the revenue from it...

2023-03-21 01:30 1795
1 ... 96979899100101102 ... 273